Author:
Bertone Vittorio,Tarantola Eleonora,Freitas Isabel
Reference30 articles.
1. Pro B, Dang NH (2004) CD26/dipeptidyl peptidase IV and its role in cancer. Histol Histopathol 19:1345–1351
2. Ohnuma K, Hosono O, Dang NH, Morimoto C (2011) Dipeptidyl peptidase in autoimmune pathophysiology. Adv Clin Chem 53:51–84
3. Gorrell MD, Abbott CA, Kähne T et al (2000) Relating structure to function in the beta-propeller domain of dipeptidylpeptidase IV. Point mutations that influence adenosine deaminase binding, antibody binding and enzyme activity. In: Langner J, Ansorge S (eds) Cellular peptidases in immune functions and diseases 2. Kluwer, New York, NY, pp 89–95
4. Ohnuma K, Inoue H, Uchiyama M, Yamochi T, Hosono O, Dang NH, Morimoto C (2006) T-cell activation via CD26 and caveolin-1 in rheumatoid synovium. Mod Rheumatol 6(1):3–13
5. Tarantola E, Bertone V, Milanesi G et al (2012) DipeptidylpeptidaseIV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats. Eur J Histochem 56:e41